Weidong Yin, Getty Images (Peter Parks)
Sinovac posts positive PhI/II data for their Covid-19 vaccine as researchers rush into a pivotal test
Beijing-based Sinovac has posted a positive preliminary snapshot of human data from the Phase I/II study of their vaccine for coronavirus, showing that the jab …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
